Nonanoate

Nonanoate

SCHEMBL107546

CCCCCCCCC(=O)[O-].[Na+]

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Nonanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 1/20 0.80
FABP3 P05413 7/20 0.72
CES2 O00748 4/20 0.67
CES1 P23141 4/20 0.67
NFKB1 P19838 1/20 0.63
FFAR3 O14843 1/20 0.62
HDAC3 O15379 1/20 0.62
HDAC1 Q13547 1/20 0.62
HDAC2 Q92769 1/20 0.62
HDAC8 Q9BY41 1/20 0.62
GPR84 Q9NQS5 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tridecanoate SCHEMBL1852615 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Hexacosanoic Acid SCHEMBL6568273 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Octanoic Acid SCHEMBL1332721 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Stearic Acid SCHEMBL583901 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Palmitic Acid SCHEMBL1958881 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Lignoceric Acid SCHEMBL4889106 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Heptanoate SCHEMBL105464 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Decanoic Acid SCHEMBL5982539 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Octanoic Acid SCHEMBL56211 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1
Palmitic Acid SCHEMBL1332725 1.00 CA1 (0.80) CA1FABP3CES2CES1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070127-A Medium chain fatty acid agglomerated crystalline salt 默沙东有限责任公司 2026-05-19 CN claimed
EP-4651897-A1 PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS Syntis Bio, Inc. (US) 2025-11-26 EP claimed
EP-3861986-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING POLYPEPTIDES AND RELATED METHODS OF DELIVERY AMRYT ENDO INC (US) 2025-11-26 EP claimed
US-20250345438-A1 PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY AMRYT ENDO INC (US) 2025-11-13 US claimed
EP-4127119-B1 WATER-GLYCOL HYDRAULIC FLUID SHELL INT RESEARCH (NL) 2025-08-27 EP claimed
WO-2025090400-A1 AGGLOMERATED CRYSTALLINE MEDIUM CHAIN FATTY ACID SALTS MERCK SHARP & DOHME LLC (US) 2025-05-01 WO claimed
CN-115484824-B Compound combination having excellent herbicidal activity 拜耳公司 2025-04-04 CN claimed
EP-3253401-B1 TREATING ACROMEGALY WITH ORAL OCTREOTIDE AMRYT ENDO INC (US) 2025-04-02 EP claimed
EP-4527456-A2 TREATING ACROMEGALY WITH ORAL OCTREOTIDE Amryt Endo, Inc. (US) 2025-03-26 EP claimed
CN-119280450-A Medical fabric dressing with long-acting disinfection and sterilization functions and preparation method thereof 孙国明 2025-01-10 CN claimed
WO-2012097155-A1 IMPROVED PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF FERRIC IRON COMPOUNDS, AND METHODS OF USE THEREOF CHIASMA INC. (US) 2012-07-19 WO claimed
US-20120093886-A1 PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY AMRYT PHARMACEUTICALS INC. 2012-04-19 US claimed
US-20120009229-A1 PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY AMRYT PHARMACEUTICALS INC. 2012-01-12 US claimed
US-20110311621-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELVERY CHIASMA, INC. 2011-12-22 US claimed
WO-2011116139-A2 IMPROVED PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELIVERY CHIASMA INC. (US) 2011-09-22 WO claimed
WO-2011116115-A1 ALISKIREN COMPOSITION COMPRISING A MEDIUM CHAIN FATTY ACID, THEIR PROCESS OF MANUFACTURING NOVARTIS AG (CH) 2011-09-22 WO claimed
EP-2343982-A2 PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY Chiasma Inc. (US) 2011-07-20 EP claimed
WO-2010032140-A2 PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY CHIASMA INC. (US) 2010-03-25 WO claimed
US-5393448-A Aqueous alkaline solution containing alkali metal carbonate, alkali metal silicate, antifoam agent and/or surfactant, sodium octanoate or nonanoate CHURCH & DWIGHT CO., INC. (US) 1995-02-28 US claimed
EP-0125641-A2 Alkanoyloxybenzenesulfonate salt production ETHYL CORPORATION (US) 1984-11-21 EP claimed